OSE Immunotherapeutics SA focuses on the development of immunotherapies for immune activation and regulation in the fields of immuno-oncology and autoimmune diseases. Its products include Tedopi that is in Phase III clinical stage for the treatment of non-small cell lung cancer, as well as in Phase II clinical trial to pancreatic and ovarian cancer; CoVepiT, a prophylactic vaccine against the SARS-CoV-2 virus; BI 765063, which is in Phase I clinical trial to treat solid tumors; and BiCKI, a novel bispecific checkpoint inhibitor platform, targeting PD-1 and innovative targets to fight primary and secondary resistance mechanisms developed by cancers. The company's products also comprise OSE-127, a humanized monoclonal antibody that is in Phase II clinical trial for the treatment of ulcerative colitis, as well as Sjögren's Syndrome; FR104, which is in Phase I clinical trial for the treatment of rheumatoid arthritis; and OSE-230, an agonist antibody against ChemR23 to resolve chronic inflammation. OSE Immunotherapeutics SA has collaborations and partnerships with GERCOR, Boehringer Ingelheim, Servier, and Chong Kun Dang Pharmaceutical Corporation. The company was formerly known as OSE Pharma SA and changed its name to OSE Immunotherapeutics SA in May 2016. OSE Immunotherapeutics SA is headquartered in Nantes, France. The 2025 version of the report offers detailed insights into the company's strategies, developments, outlook and drivers. In addition to SWOT Analysis and Financial Overview, the report analyzes key projects, business description, products, services, brands, operating locations, subsidiaries and affiliates of OSE IMMUNO.
OSE IMMUNO business operations across the value chain are included. Further, all major operating and planned locations, related contacts, details of subsidiaries and partnerships of OSE IMMUNO are also analyzed.
Detailed SWOT Analysis of the company including key strengths and weaknesses of OSE IMMUNO , on which it can build its business along with potential opportunities and threats in the near to medium term future are detailed.
Key employees of the company including the management team and board of directors are listed with their designations. Further, statistics on key parameters such as employee count, organization structure etc is provided.
Financial analysis of OSE IMMUNO including key ratios, income statement, cash flow statement and balance sheet are provided for the company. In addition, Key historical events, summary analysis of OSE IMMUNO and all latest updates of the company are provided.
The 2025 version of OSE IMMUNO report is presented after intensive primary and secondary research processes and it presents the insights in a complete impartial and reader friendly format.
TABLE OF CONTENTS
1.1 List of Tables
1.2 List of Figures
2 Introduction to the Company
2.1 OSE IMMUNO- Key Facts
2.2 OSE IMMUNO- Geographic Locations
2.3 OSE IMMUNO- Subsidiaries and Affiliates
2.4 OSE IMMUNO- Business Divisions
2.5 OSE IMMUNO- Key Employees
2.5.1 Management Team
2.5.2 Board of Directors
3. OSE IMMUNO Strategic Analysis Review
3.1 OSE IMMUNO- Key Strategies
3.2 OSE IMMUNO- Company Outlook Statement
3.3 OSE IMMUNO- SWOT Analysis
3.3.1 OSE IMMUNO- Key Strengths
3.3.2 OSE IMMUNO- Key Weaknesses
3.3.3 OSE IMMUNO- Potential Opportunities
3.3.4 OSE IMMUNO- Potential Threats
3.4 OSE IMMUNO- Key Competitors
4. Business Description of the Company
4.1 OSE IMMUNO- Business Overview
4.2 OSE IMMUNO- Operations by Segment
5 Products and Services Details
5.1 OSE IMMUNO- Key Products
5.2 OSE IMMUNO- Key Service Areas
5.3 OSE IMMUNO- Key Brands
6 Company Developments
6.1 OSE IMMUNO- Company History
6.2 OSE IMMUNO- Latest Developments
7 Financial Analysis
7.1 OSE IMMUNO- Income Statements
7.2 OSE IMMUNO- Balance Sheet
7.3 OSE IMMUNO- Cash Flow Statements
8 Competitors and Industry Analysis
8.1 OSE IMMUNO- Direct Competitors
8.2 OSE IMMUNO- Competitor Financial Ratios comparison
8.3 OSE IMMUNO- Competitor Stock Charts Comparison
8.4 OSE IMMUNO- Industry Analysis
9 Appendix
9.1 About SWOTreports
9.2 Sources and Methodology
9.3 Contact Information
P.S.Financial Analysis will be provided only for companies reporting financial data.
At SWOT Reports, we understand the importance of informed decision-making in today's dynamic business landscape. To help you experience the depth and quality of our market research reports, we offer complimentary samples tailored to your specific needs.
Start Now! Please fill the form below for your free sample.
Evaluate Our Expertise: Our reports are crafted by industry experts and seasoned analysts. Requesting a sample allows you to assess the depth of research and the caliber of insights we provide.
Tailored to Your Needs: Let us know your industry, market segment, or specific topic of interest. Our free samples are customized to ensure relevance to your business objectives.
Witness Actionable Insights: See firsthand how our reports go beyond data, offering actionable insights and strategic recommendations that can drive your business forward.
Embark on your journey towards strategic decision-making by requesting a free sample from SWOT Reports. Experience the caliber of insights that can transform the way you approach your business challenges.
Gain valuable insights into the company for academic or business research purposes with this comprehensive profile. Key elements, such as SWOT analysis and corporate strategy, are included to support your research needs effectively.
Customer and Supplier Identification: Analyze the company’s business structure, operations, major products, services, and strategies to identify potential customers and suppliers.
Leverage a detailed SWOT analysis to understand and evaluate your competitors' business structures, strategies, and core performance metrics. This analysis offers an up-to-date and objective perspective on the company’s strengths, weaknesses, opportunities, and threats.
Didn’t find what you’re looking for? TALK TO OUR ANALYST TEAM
Need something within your budget? NO WORRIES! WE GOT YOU COVERED!